JP2022539238A5 - - Google Patents
Info
- Publication number
- JP2022539238A5 JP2022539238A5 JP2022500019A JP2022500019A JP2022539238A5 JP 2022539238 A5 JP2022539238 A5 JP 2022539238A5 JP 2022500019 A JP2022500019 A JP 2022500019A JP 2022500019 A JP2022500019 A JP 2022500019A JP 2022539238 A5 JP2022539238 A5 JP 2022539238A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- gene therapy
- complement
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871058P | 2019-07-05 | 2019-07-05 | |
| US62/871,058 | 2019-07-05 | ||
| US201962871700P | 2019-07-08 | 2019-07-08 | |
| US62/871,700 | 2019-07-08 | ||
| US201962875925P | 2019-07-18 | 2019-07-18 | |
| US62/875,925 | 2019-07-18 | ||
| US201962935569P | 2019-11-14 | 2019-11-14 | |
| US62/935,569 | 2019-11-14 | ||
| PCT/US2020/040741 WO2021007111A1 (en) | 2019-07-05 | 2020-07-02 | Viral vector therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022539238A JP2022539238A (ja) | 2022-09-07 |
| JP2022539238A5 true JP2022539238A5 (https=) | 2024-03-25 |
Family
ID=74114222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500019A Pending JP2022539238A (ja) | 2019-07-05 | 2020-07-02 | ウイルスベクター療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220249706A1 (https=) |
| EP (1) | EP3996744A4 (https=) |
| JP (1) | JP2022539238A (https=) |
| AU (1) | AU2020311330A1 (https=) |
| CA (1) | CA3143257A1 (https=) |
| WO (1) | WO2021007111A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11903994B2 (en) | 2015-10-07 | 2024-02-20 | Apellis Pharmaceuticals, Inc. | Dosing regimens |
| IL269844B2 (en) * | 2017-04-07 | 2025-01-01 | Apellis Pharmaceuticals Inc | Dosage regimens and related compositions and methods |
| WO2019118938A1 (en) | 2017-12-15 | 2019-06-20 | Apellis Pharmaceuticals, Inc. | Dosing regimens and related compositions and methods |
| CN119264211A (zh) | 2018-08-27 | 2025-01-07 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| EP4346843A4 (en) * | 2021-05-27 | 2025-05-21 | Apellis Pharmaceuticals, Inc. | GENOME EDITING OF COMPLEMENT |
| CA3245921A1 (en) * | 2022-03-17 | 2023-09-21 | Adverum Biotechnologies, Inc. | Antibody Cassettes of Constituent 3 Anti-Complement, Vectorization and Therapeutic Application |
| CN120359233A (zh) * | 2022-11-24 | 2025-07-22 | 阿麦达斯制药美国有限责任公司 | 用于基于载体的疗法的坎普他汀类似物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000029033A2 (en) * | 1998-11-17 | 2000-05-25 | The General Hospital Corporation | A method of genetic vector delivery |
| JP2007112715A (ja) * | 2004-01-22 | 2007-05-10 | Dnavec Research Inc | 繰返し投与を伴うベクターの発現を継続させる方法 |
| MX366404B (es) * | 2012-11-15 | 2019-07-08 | Apellis Pharmaceuticals Inc | Analogos de compstatina de celula reactiva, de acción prolongada u objetivos y composiciones y metodos relacionados. |
| US10238700B2 (en) * | 2014-01-02 | 2019-03-26 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
-
2020
- 2020-07-02 WO PCT/US2020/040741 patent/WO2021007111A1/en not_active Ceased
- 2020-07-02 AU AU2020311330A patent/AU2020311330A1/en active Pending
- 2020-07-02 CA CA3143257A patent/CA3143257A1/en active Pending
- 2020-07-02 JP JP2022500019A patent/JP2022539238A/ja active Pending
- 2020-07-02 EP EP20836586.6A patent/EP3996744A4/en active Pending
- 2020-07-02 US US17/624,755 patent/US20220249706A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539238A5 (https=) | ||
| JP7707261B2 (ja) | 筋疾患の治療のための改変ａａｖカプシドポリペプチド | |
| TWI719223B (zh) | 最佳化之微小肌萎縮蛋白基因和表現卡匣及彼等之用途 | |
| CA2909733C (en) | Effective delivery of large genes by dual aav vectors | |
| ES2989774T3 (es) | Factor IX modificado, y composiciones, métodos y utilizaciones para la transferencia génica a células, órganos y tejidos | |
| JP2020048571A5 (https=) | ||
| KR101014207B1 (ko) | 아데노-결합 바이러스 (ａａｖ) 서열을 검출 및/또는 확인하는 방법 및 그 방법에 의해 확인된 신규한 서열을 분리하는 방법 | |
| US10640785B2 (en) | Virus vectors for highly efficient transgene delivery | |
| US10392632B2 (en) | AAV8 vector with enhanced functional activity and methods of use thereof | |
| AU2003295312B2 (en) | Improved rAAV expression systems for genetic modification of specific capsid proteins | |
| US20180036428A1 (en) | Capsid-modified raav vectors and methods of use | |
| US20170007720A1 (en) | Methods and compositions for gene delivery to on bipolar cells | |
| US12564647B2 (en) | Optimized expression cassettes for gene therapy | |
| JP2015514427A (ja) | Ａａｖカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法 | |
| JP2021512649A5 (https=) | ||
| TW201629225A (zh) | 第九因子基因療法 | |
| CN114945583A (zh) | Α-肌聚糖的腺相关病毒载体递送和肌营养不良症的治疗 | |
| CN111876432B (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| AU2023258039A1 (en) | B-cell lymphoma 2–associated anthanogene 3 (bag3) gene therapy using aav vector | |
| JP2022553083A (ja) | アデノ随伴ウイルスベクターに基づく遺伝性血管浮腫のための遺伝子治療 | |
| CN118108810A (zh) | 一种靶向骨骼肌的重组腺相关病毒及其应用 | |
| CA2500523A1 (en) | Vp2-modified raav vector compositions and uses therefor | |
| CN115885043A (zh) | 用于dwarf开放阅读框的腺相关病毒载体 | |
| EP4410988A1 (en) | An aav2-vector variant for targeted transfer of genes | |
| KR20250102134A (ko) | Atp7b 유전자 요법 |